Published in N Engl J Med on March 30, 2006
Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med (2005) 11.89
Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med (2013) 4.77
Preauthorization of CT and MRI examinations: assessment of a managed care preauthorization program based on the ACR Appropriateness Criteria and the Royal College of Radiology guidelines. J Am Coll Radiol (2006) 1.56
The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization. Diabetes Res Clin Pract (2005) 1.15
Organisational efforts to improve quality while reducing healthcare disparities: the case of breast cancer screening among Arab women in Israel. Qual Saf Health Care (2010) 1.02
Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care (2004) 0.94
Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis. Syst Rev (2014) 0.92
Medical management of terrorist attacks. Isr Med Assoc J (2002) 0.91
Deaths following influenza vaccination--background mortality or causal connection? Vaccine (2007) 0.89
When is an epidemic an epidemic? Isr Med Assoc J (2002) 0.84
Changes in the potential quantum yield of photosystem II and the integrity of cell membranes relative to the elemental content of the epilithic desert lichen Ramalina maciformis. Environ Toxicol Chem (2002) 0.84
[Utilization patterns of CT and MRI in Israel]. Harefuah (2003) 0.83
[Quality of community-based healthcare services]. Harefuah (2004) 0.81
The patient-perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care. Diabetes Metab Res Rev (2012) 0.81
[Threshold values for cost-effectiveness ratio and public funding of medical technologies]. Harefuah (2007) 0.81
Health systems and policy research evidence in health policy making in Israel: what are researchers' practices in transferring knowledge to policy makers? Health Res Policy Syst (2014) 0.81
Year 2006 update of the National List of Health Services--an endless process. Isr Med Assoc J (2006) 0.80
[Clinical trials--historical development, regulation and updated data]. Harefuah (2004) 0.79
Continuation of statin therapy and primary prevention of nonfatal cardiovascular events. Am J Cardiol (2012) 0.79
EQ-5D as a generic measure of health-related quality of life in Israel: reliability, validity and responsiveness. Isr Med Assoc J (2010) 0.78
Adoption of cost consciousness: attitudes, practices, and knowledge among Israeli physicians. Int J Technol Assess Health Care (2008) 0.78
Optimism of health care workers during a disaster: a review of the literature. Emerg Health Threats J (2012) 0.78
Quality of life and patient-perceived difficulties in the treatment of type 2 diabetes. Rev Diabet Stud (2012) 0.78
Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Isr Med Assoc J (2003) 0.76
It is time to fortify basic foods in Israel according to the Canadian model. Isr Med Assoc J (2004) 0.76
Health Value Added (HVA): linking strategy, performance, and measurement in healthcare organizations. Isr Med Assoc J (2003) 0.76
Is disease management "ready" for Israel? Isr Med Assoc J (2006) 0.75
[Robot-assisted surgery--point of no return?]. Harefuah (2011) 0.75
In anticipation of patient participation. Isr Med Assoc J (2009) 0.75
[The over the counter drugs reform in Israel--two years later]. Harefuah (2011) 0.75
Personalized medicine and health economics: is small the new big? A white paper. Isr Med Assoc J (2013) 0.75
[Professionalism in healthcare organizations--a unique model in the Assuta Medical Centers Network]. Harefuah (2015) 0.75
Health technology management in Israel: HTA in action. Int J Technol Assess Health Care (2009) 0.75
[Generic drug substitution]. Harefuah (2006) 0.75
Diabolical, haunting terror--here and now. Isr Med Assoc J (2002) 0.75
[Economic evaluation of health technologies: theory and practice]. Harefuah (2008) 0.75
Patients' and Care Partners' Perspectives on Dignity and Respect During Acute Care Hospitalization. J Patient Saf (2017) 0.75
[Laparascopic surgery and robotic-guided surgery]. Harefuah (2009) 0.75
[Over the counter drugs--a new era in Israel]. Harefuah (2011) 0.75
Quality assessment in primary military clinics of the Israel Defense Forces Northern Command. Mil Med (2006) 0.75
Perspective: the case for subspecialty clinical learning in early medical education-moving from case-based to patient-based learning. Acad Med (2008) 0.75
[Personalized medicine--the future is already here]. Harefuah (2011) 0.75
[Public financing for off-label use of drugs]. Harefuah (2011) 0.75
British medical journals play politics. Isr Med Assoc J (2009) 0.75
Prostate cancer: do patients understand what they choose? Isr Med Assoc J (2013) 0.75
Economic evaluation of medical technologies. Isr Med Assoc J (2005) 0.75
[Tsunami--the death waves]. Harefuah (2005) 0.75
The use of medical informatics as a management tool for community health services during the 2006 Israel-Lebanon War. Isr Med Assoc J (2006) 0.75
A decade to the Israeli Center for Technology Assessment in Health Care. Isr Med Assoc J (2008) 0.75
[Why viral (SARS, Ebola and AIDS) epidemics now?]. Harefuah (2003) 0.75
[Assessment of health related quality of life--part 3--preference based measures]. Harefuah (2008) 0.75
[Exclusivity of data in drug registration files and Israel's international status with regard to intellectual property rights protection]. Harefuah (2004) 0.75
[Lifestyle modification--a behavioral and educational challenge]. Harefuah (2010) 0.75
Impact of new medical technologies on health expenditures in Israel 2000-07. Int J Technol Assess Health Care (2007) 0.75
[Assessment of health related quality of life--part 2--health state measures]. Harefuah (2008) 0.75
[Clinical trials--selected topics]. Harefuah (2004) 0.75
Response to health in the Occupied Palestinian Territory. Lancet (2011) 0.75
[The crucial encounter between technology and medicine]. Harefuah (2008) 0.75
[Risk-sharing scheme in Israel--Kuvan as an allegory]. Harefuah (2012) 0.75
[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats]. Harefuah (2010) 0.75
The games go on: British Medical Journals play politics, again. Isr Med Assoc J (2012) 0.75
Hospital management of a bioterror event. Isr Med Assoc J (2002) 0.75
[Medical resonance imaging (MRI)--the technology, the regulation and the utilization pattern in Israel]. Harefuah (2012) 0.75
[The physician manager--building a clinical leadership in community medicine--the Maccabi Healthcare Services (MHS) model]. Harefuah (2008) 0.75
[Assessment of health related quality of life--Part 1--Direct measures]. Harefuah (2008) 0.75
[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions]. Harefuah (2010) 0.75